文献速递临床试验与 GCP医学人工智能与信息学医学教育与科研方法

数字干预预防青少年抑郁试验方案:未来防护研究

A trial protocol for the effectiveness of digital interventions for preventing depression in adolescents: The Future Proofing Study.
PubMed 文献 · Trials · 2020-01-02

未来防护研究是一项学校整群随机对照试验,计划纳入最多1万名澳大利亚八年级学生,评估智能手机应用递送的认知行为疗法(CBT)能否预防抑郁。主要结局为抑郁症状,次要结局包括心理困扰、焦虑和失眠;12个月随访时抑郁症状升高的干预组参与者将进入个体随机对照试验,接受针对睡眠困难的第二款CBT应用或对照。

要点

  • 学校整群随机分配至CBT干预应用(SPARX)或非活性对照,主要结局为抑郁症状。
  • 12个月随访时抑郁症状升高的干预组参与者进入个体随机试验,比较睡眠CBT应用(Sleep Ninja)与对照。
  • 评估在干预后及基线后6、12、24、36、48、60个月进行,主要分析采用意向性治疗和混合效应模型。

核心结论

  • 这是首个在学校学生中大规模测试智能手机应用预防抑郁有效性的试验,结果将为该方法的可行性及学校场景部署决策提供依据。

研究设计与样本

  • 整群随机对照试验,计划纳入最多10000名澳大利亚八年级中学生,学校按整群随机分配至CBT干预应用(SPARX)或非活性对照。
  • 12个月随访时,干预组中抑郁症状升高的参与者进入个体随机对照试验(Stage II),随机接受针对睡眠困难的第二款CBT应用(Sleep Ninja)或对照。
  • 评估在干预后及基线后6、12、24、36、48、60个月进行,主要分析采用意向性治疗和混合效应模型。

关键数值与推荐

  • 主要结局为抑郁症状,次要结局包括心理困扰、焦虑和失眠。
  • Stage II随机分组条件为12个月随访时干预组中抑郁症状升高的参与者。

临床怎么用

  • 若证实有效,可为学校场景是否及如何部署智能手机CBT预防项目提供政策和委托决策依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression frequently first emerges during adolescence, and one in five young people will experience an episode of depression by the age of 18 years. Despite advances in treatment, there has been limited progress in addressing the burden at a population level. Accordingly, there has been growing interest in prevention approaches as an additional pathway to address depression. Depression can be prevented using evidence-based psychological programmes. However, barriers to implementing and accessing these programmes remain, typically reflecting a requirement for delivery by clinical experts and high associated delivery costs. Digital technologies, specifically smartphones, are now considered a key strategy to overcome the barriers inhibiting access to mental health programmes. The Future Proofing Study is a large-scale school-based trial investigating whether cognitive behaviour therapies (CBT) delivered by smartphone application can prevent depression. METHODS: A randomised controlled trial targeting up to 10,000 Year 8 Australian secondary school students will be conducted. In Stage I, schools will be randomised at the cluster level either to receive the CBT intervention app (SPARX) or to a non-active control group comparator. The primary outcome will be symptoms of depression, and secondary outcomes include psychological distress, anxiety and insomnia. At the 12-month follow-up, participants in the intervention arm with elevated depressive symptoms will participate in an individual-level randomised controlled trial (Stage II) and be randomised to receive a second CBT app which targets sleep difficulties (Sleep Ninja) or a control condition. Assessments will occur post intervention (both trial stages) and at 6, 12, 24, 36, 48 and 60 months post baseline. Primary analyses will use an intention-to-treat approach and compare changes in symptoms from baseline to follow-up relative to the control group using mixed-effect models. DISCUSSION: This is the first trial testing the effectiveness of smartphone apps delivered to school students to prevent depression at scale. Results from this trial will provide much-needed insight into the feasibility of this approach. They stand to inform policy and commission decisions concerning if and how such programmes should be deployed in school-based settings in Australia and beyond. TRIAL REGISTRATION: Australian and New Zealand Clinical Trial Registry, ACTRN12619000855123. Registered on 31 May 2019. Clinical Trial Notification Scheme (CTN), CT-2019-CTN-02110-1-v1. Registered on 30 June 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Werner-Seidler A, Huckvale K, Larsen ME, et al. A trial protocol for the effectiveness of digital interventions for preventing depression in adolescents: The Future Proofing Study. Trials. 2020. PMID: 31898512. doi:10.1186/s13063-019-3901-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。